Aehr Test Systems reported its second-quarter earnings for fiscal year 2026, revealing a decline in revenue and a net loss, which led to a drop in its stock price. The company, known for its ...

As the nation experiences what many experts believe is the second-largest wave of COVID infections since the pandemic started, many Americans will be checking to make sure they don’t have the ...

Aehr Test Systems (NASDAQ:AEHR) Q4 2025 Earnings Call Transcript July 8, 2025 Aehr Test Systems beats earnings expectations. Reported EPS is $-0.01, expectations were $-0.015. Operator: Greetings.

As Trump’s ramblings about his cognitive test accidentally reveals his unfitness, a critic of political media explains how the press fails to connect his mental decline to the real-world horrors he’s ...

GoTranscript today announced the addition of 70+ new languages to its human transcription and custom labeling services, bringing total coverage to 140+ languages. The expansion focuses on large, under ...

Aehr Test Systems (NASDAQ:AEHR) Q1 2026 Earnings Call Transcript October 6, 2025 Aehr Test Systems reports earnings inline with expectations. Reported EPS is $0.01 EPS, expectations were $0.01.

Greetings. Welcome to the Aehr Test Systems Fiscal 2026 First Quarter Financial Results Conference Call. [Operator Instructions] Please note, this conference is being recorded. I will now turn the ...

Greetings. Welcome to the Aehr Test Systems Fiscal 2025 Third Quarter Financial Results Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the ...

Alfredo has a PhD in Astrophysics and a Master's in Quantum Fields and Fundamental Forces from Imperial College London. Alfredo has a PhD in Astrophysics and a Master's in Quantum Fields and ...

The Food and Drug Administration on Monday approved Guardant Health’s blood test, called Shield, to screen for colon cancer. The test isn't meant to replace colonoscopies, but is generating enthusiasm ...